Product Name: CTAG2 Antibody
Species Reactivity: Human
Tested Applications: IHC-P, WB
Applications: For WB starting dilution is: 1:1000For IHC-P starting dilution is: 1:10~50
User Note: Optimal dilutions for each application to be determined by the researcher.
Predicted Molecular Weight: 21 kDa
Immunogen: This CTAG2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 122-149 amino acids from the Central region of human CTAG2.
Host Species: Rabbit
Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.
Physical State: Liquid
CAS NO.: 105628-72-6
Product: Hydroxyfasudil
Buffer: Supplied in PBS with 0.09% (W/V) sodium azide.
Concentration: 0.3 mg/ml
Storage Conditions: Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Clonality: Polyclonal
Conjugate: Unconjugated
Alternate Names: Cancer/testis antigen 2, CT2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 62, CT62, L antigen family member 1, LAGE-1, CTAG2, ESO2, LAGE1
Accession NO.: O75638
Protein Ino:
Official Symbol: CTAG2
Geneid: 30848
Background: This gene encodes an autoimmunogenic tumor antigen thatbelongs to the ESO/LAGE family of cancer-testis antigens. Thisprotein is expressed in a wide array of cancers including melanoma,breast cancer, bladder cancer and prostate cancer. This protein isalso expressed in normal testis tissue. An alternative open readingframe product of this gene has been described in PMID 10399963.This alternate protein, termed CAMEL, is a tumor antigen that isrecognized by melanoma-specific cytotoxic T-lymphocytes. Alternatesplicing results in multiple transcript variants. [provided byRefSeq].
PubMed ID:http://aac.asm.org/content/37/5/1197.abstract
